BioMarin Pharmaceutical Inc. buy Barclays PLC
Start price
28.01.26
/
50%
€47.65
Target price
28.01.27
€66.71
Performance (%)
13.12%
Price
19.02.26
€53.90
Summary
This prediction is currently active. The prediction currently has a performance of 13.12%. This prediction currently runs until 28.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| BioMarin Pharmaceutical Inc. | 6.690% |
| iShares Core DAX® | 0,39 % |
| iShares Nasdaq 100 | 1,31 % |
| iShares Nikkei 225® | -0,46 % |
| iShares S&P 500 | 1,31 % |
Comments by Barclays_PLC for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $80.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€68.62
28.10.26
28.10.26
14.93%
19.02.26
19.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
04.10.24
04.10.24
€78.35
04.10.25
04.10.25
-24.70%
05.10.25
05.10.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.46
06.08.24
06.08.24
€100.74
06.08.25
06.08.25
-34.76%
07.08.25
07.08.25